XTX Topco’s Applied Therapeutics APLT Stock Holding History

XTX Topco’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23,579	Closed	-$14.3K	–	3294
2025 Q3	$14.3K	Buy	+23,579	New	+$11.1K	﹤0.01%	2384
2025 Q1	–	Sell	-173,568	Closed	-$149K	–	2382
2024 Q4	$149K	Buy	173,568 +111,128	+178%	+$697K	0.01%	1669
2024 Q3	$531K	Buy	+62,440	New	+$368K	0.04%	772
2024 Q1	–	Sell	-81,371	Closed	-$273K	–	1812
2023 Q4	$273K	Buy	+81,371	New	+$203K	0.06%	707

Other funds holding APLT

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

XTX Topco's APLT Position: Q4 2025 in Review

XTX Topco sold out of Applied Therapeutics (APLT) in Q4 2025, closing a stake of 23,579 shares — an estimated $14.3K sold.

XTX Topco first reported a position in APLT in Q4 2023 and held it in 4 quarters. The position peaked at $531K in Q3 2024. 52 funds tracked by Wall St. Rank hold APLT as of Q4 2025.

XTX Topco reported no remaining Applied Therapeutics position as of Q4 2025 after selling out during the quarter.
XTX Topco sold 23,579 Applied Therapeutics shares in Q4 2025, an estimated $14.3K.
XTX Topco first reported a position in Applied Therapeutics in Q4 2023 and held it in 4 quarters.
XTX Topco's Applied Therapeutics position peaked at $531K in Q3 2024.
52 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.